266 related articles for article (PubMed ID: 19344719)
1. Antifibrotic effects of CXCL9 and its receptor CXCR3 in livers of mice and humans.
Wasmuth HE; Lammert F; Zaldivar MM; Weiskirchen R; Hellerbrand C; Scholten D; Berres ML; Zimmermann H; Streetz KL; Tacke F; Hillebrandt S; Schmitz P; Keppeler H; Berg T; Dahl E; Gassler N; Friedman SL; Trautwein C
Gastroenterology; 2009 Jul; 137(1):309-19, 319.e1-3. PubMed ID: 19344719
[TBL] [Abstract][Full Text] [Related]
2. Liver inflammation in a mouse model of Th1 hepatitis despite the absence of invariant NKT cells or the Th1 chemokine receptors CXCR3 and CCR5.
Cripps JG; Celaj S; Burdick M; Strieter RM; Gorham JD
Lab Invest; 2012 Oct; 92(10):1461-71. PubMed ID: 22906987
[TBL] [Abstract][Full Text] [Related]
3. Interleukin-27 and IFNγ regulate the expression of CXCL9, CXCL10, and CXCL11 in hepatitis.
Basset L; Chevalier S; Danger Y; Arshad MI; Piquet-Pellorce C; Gascan H; Samson M
J Mol Med (Berl); 2015 Dec; 93(12):1355-67. PubMed ID: 26199110
[TBL] [Abstract][Full Text] [Related]
4. Serum chemokine receptor CXCR3 ligands are associated with progression, organ dysfunction and complications of chronic liver diseases.
Tacke F; Zimmermann HW; Berres ML; Trautwein C; Wasmuth HE
Liver Int; 2011 Jul; 31(6):840-9. PubMed ID: 21645215
[TBL] [Abstract][Full Text] [Related]
5. Progression of autoimmune hepatitis is mediated by IL-18-producing dendritic cells and hepatic CXCL9 expression in mice.
Ikeda A; Aoki N; Kido M; Iwamoto S; Nishiura H; Maruoka R; Chiba T; Watanabe N
Hepatology; 2014 Jul; 60(1):224-36. PubMed ID: 24700550
[TBL] [Abstract][Full Text] [Related]
6. Chemokine Cxcl9 attenuates liver fibrosis-associated angiogenesis in mice.
Sahin H; Borkham-Kamphorst E; Kuppe C; Zaldivar MM; Grouls C; Al-samman M; Nellen A; Schmitz P; Heinrichs D; Berres ML; Doleschel D; Scholten D; Weiskirchen R; Moeller MJ; Kiessling F; Trautwein C; Wasmuth HE
Hepatology; 2012 May; 55(5):1610-9. PubMed ID: 22237831
[TBL] [Abstract][Full Text] [Related]
7. Hepatectomy leads to loss of TRAIL-expressing liver NK cells via downregulation of the CXCL9-CXCR3 axis in mice.
Yano T; Ohira M; Nakano R; Tanaka Y; Ohdan H
PLoS One; 2017; 12(10):e0186997. PubMed ID: 29088306
[TBL] [Abstract][Full Text] [Related]
8. CXCL10 promotes liver fibrosis by prevention of NK cell mediated hepatic stellate cell inactivation.
Hintermann E; Bayer M; Pfeilschifter JM; Luster AD; Christen U
J Autoimmun; 2010 Dec; 35(4):424-35. PubMed ID: 20932719
[TBL] [Abstract][Full Text] [Related]
9. Intrahepatic levels of CXCR3-associated chemokines correlate with liver inflammation and fibrosis in chronic hepatitis C.
Zeremski M; Petrovic LM; Chiriboga L; Brown QB; Yee HT; Kinkhabwala M; Jacobson IM; Dimova R; Markatou M; Talal AH
Hepatology; 2008 Nov; 48(5):1440-50. PubMed ID: 18798334
[TBL] [Abstract][Full Text] [Related]
10. Gene profile of chemokines on hepatic stellate cells of schistosome-infected mice and antifibrotic roles of CXCL9/10 on liver non-parenchymal cells.
Liang YJ; Luo J; Lu Q; Zhou Y; Wu HW; Zheng D; Ren YY; Sun KY; Wang Y; Zhang ZS
PLoS One; 2012; 7(8):e42490. PubMed ID: 22905138
[TBL] [Abstract][Full Text] [Related]
11. CXCR3 ligands contribute to Th1-induced inflammation but not to homing of Th1 cells into the lung.
Manicone AM; Burkhart KM; Lu B; Clark JG
Exp Lung Res; 2008 Sep; 34(7):391-407. PubMed ID: 18716926
[TBL] [Abstract][Full Text] [Related]
12. Peripheral CXCR3-associated chemokines as biomarkers of fibrosis in chronic hepatitis C virus infection.
Zeremski M; Dimova R; Brown Q; Jacobson IM; Markatou M; Talal AH
J Infect Dis; 2009 Dec; 200(11):1774-80. PubMed ID: 19848607
[TBL] [Abstract][Full Text] [Related]
13. Chemokine and chemokine receptor interactions provide a mechanism for selective T cell recruitment to specific liver compartments within hepatitis C-infected liver.
Shields PL; Morland CM; Salmon M; Qin S; Hubscher SG; Adams DH
J Immunol; 1999 Dec; 163(11):6236-43. PubMed ID: 10570316
[TBL] [Abstract][Full Text] [Related]
14. Enhanced T cell transmigration across the murine liver sinusoidal endothelium is mediated by transcytosis and surface presentation of chemokines.
Schrage A; Wechsung K; Neumann K; Schumann M; Schulzke JD; Engelhardt B; Zeitz M; Hamann A; Klugewitz K
Hepatology; 2008 Oct; 48(4):1262-72. PubMed ID: 18697212
[TBL] [Abstract][Full Text] [Related]
15. C-X-C Motif Chemokine Ligand 9 and Its CXCR3 Receptor Are the Salt and Pepper for T Cells Trafficking in a Mouse Model of Gaucher Disease.
Magnusen AF; Rani R; McKay MA; Hatton SL; Nyamajenjere TC; Magnusen DNA; Köhl J; Grabowski GA; Pandey MK
Int J Mol Sci; 2021 Nov; 22(23):. PubMed ID: 34884512
[TBL] [Abstract][Full Text] [Related]
16. Characteristics of Allergic Pulmonary Inflammation in CXCR3Knockout Mice Sensitized and Challenged with House Dust Mite Protein.
Liu Z; Chen H; Chen X; Gao J; Guo Z
PLoS One; 2016; 11(10):e0162905. PubMed ID: 27727269
[TBL] [Abstract][Full Text] [Related]
17. Type 3 innate lymphoid cell: a new player in liver fibrosis progression.
Wang S; Li J; Wu S; Cheng L; Shen Y; Ma W; She W; Yang C; Wang J; Jiang W
Clin Sci (Lond); 2018 Dec; 132(24):2565-2582. PubMed ID: 30459204
[TBL] [Abstract][Full Text] [Related]
18. Abundant expression of CXCL9 (MIG) by stromal cells that include dendritic cells and accumulation of CXCR3+ T cells in lymphocyte-rich gastric carcinoma.
Ohtani H; Jin Z; Takegawa S; Nakayama T; Yoshie O
J Pathol; 2009 Jan; 217(1):21-31. PubMed ID: 18980207
[TBL] [Abstract][Full Text] [Related]
19. Novel role of the CXC chemokine receptor 3 in inflammatory response to arterial injury: involvement of mTORC1.
Schwarz JB; Langwieser N; Langwieser NN; Bek MJ; Seidl S; Eckstein HH; Lu B; Schömig A; Pavenstädt H; Zohlnhöfer D
Circ Res; 2009 Jan; 104(2):189-200. PubMed ID: 19059841
[TBL] [Abstract][Full Text] [Related]
20. The CXC Chemokine Receptor 3 Inhibits Autoimmune Cholangitis
Liu QZ; Ma WT; Yang JB; Zhao ZB; Yan K; Yao Y; Li L; Miao Q; Gershwin ME; Lian ZX
Front Immunol; 2018; 9():1090. PubMed ID: 29868034
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]